Brief Title
Acute Cholecystitis With Concomitant Choledocholithiasis: Unicentric Study of Prevalence and Predictive Factors
Official Title
Acute Cholecystitis With Concomitant Choledocholithiasis: Unicentric Study of Prevalence and Predictive Factors for Its Diagnosis and Management
Brief Summary
The management of cholelithiasis with choledocolithiasis is extensively known, whereas for Acute Calculous Cholecystitis (ACC) with choledocolithiasis or common bile duct stones (CBDS), a common entity, there is a lack of protocols for optimising treatment. The main hypothesis of our study is: a correct stratification of the concomitant CBDS probability at ACC diagnosis would optimize its treatment as early targeted treatment could be performed. One-step management of ACC with CBDS by a specialised hepatobiliary team would represent a benefit to the patient in terms of morbi-mortality, admission time and number of admissions. The aim of our study is to identify high / intermediate probability criteria for CBDS associated when diagnosing CA. This is a retrospective study of patients who were operated on with an emergent cholecystectomy in our center from 01/2012 to 12/2019.
Detailed Description
Data will be obtained from the hospital (Consorci Sanitari del Maresme) clinical database. The Ethics Committee approval has been obtained.
Study Type
Observational
Primary Outcome
CBDS risk
Secondary Outcome
Intraoperative cholangiography
Condition
Acute Cholecystitis
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Estimated Enrollment
120
Start Date
February 15, 2021
Completion Date
April 15, 2021
Primary Completion Date
April 15, 2021
Eligibility Criteria
Inclusion Criteria: - Age ≥18 years Exclusion Criteria: - Non urgent cholecystectomy
Gender
All
Ages
18 Years - 100 Years
Accepts Healthy Volunteers
No
Contacts
, 0034937417700, [email protected]
Administrative Informations
NCT ID
NCT04739891
Organization ID
CHOLEPREV2021
Responsible Party
Principal Investigator
Study Sponsor
Hospital de Mataró
Study Sponsor
, ,
Verification Date
February 2021